ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese

Metabolism: Clinical and Experimental

Volumn 58, Issue 10, 2009, Pages 1415-1423

  Apelt, Nadja ^a   da Silva, Alda Pereira ^a   Ferreira, Joana ^a   Alho, Irina ^a   Monteiro, Cristina ^b   Marinho, Cláudia ^a   Teixeira, Pedro ^b   Sardinha, Luís ^b   Laires, Ma José ^b   Mascarenhas, Mário Rui ^c   Bicho, Manuel Pires ^a  

^a FML   (Portugal)

^b UNIVERSIDADE DE LISBOA   (Portugal)

^c Centre for Endocrinology Diabetes and Metabolism   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; CHOLESTEROL; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN TYROSINE PHOSPHATASE; RIBOFLAVIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUTRITION; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ACID PHOSPHATASE; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ERYTHROCYTES; FEMALE; GENOTYPE; GLUTATHIONE REDUCTASE; HOMEOSTASIS; HUMANS; MIDDLE AGED; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OBESITY; OXIDATIVE STRESS; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS; RIBOFLAVIN; RISK ASSESSMENT; YOUNG ADULT;

EID: 70249136887     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.007     Document Type: Article

References (46)

1. Chiarugi P., Taddei M.L., Giannoni E., et al. Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. J Biol Chem 277 (2002) 37331-37338
2. Bottini N., Gloria-Bottini F., Borgiani P., et al. Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms. Metabolism 53 (2004) 995-1001
3. Lucarini N., Antonacci E., Bottini N., et al. Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus. Hum Biol 69 (1997) 509-515
4. Pandey S.K., Yu X.X., Watts L.M., et al. Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice. J Biol Chem 282 (2007) 14291-14299
5. Bottini N., Saccucci P., Piciullo A., et al. Convulsive disorder and the genetics of signal transduction; a study of a low molecular weight protein tyrosine phosphatase in a pediatric sample. Neurosci Lett 333 (2002) 159-162
6. Lucarini N., Finocchi G., Gloria-Bottini E., et al. A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphism. Experientia 46 (1990) 90-91
7. Swallow D.M., Povey S., and Harris H. Activity of the "red cell" acid phosphatase locus in other tissues. Ann Hum Genet 37 (1973) 31-38
8. Gloria-Bottini F., Lucarelli P., Amante A., et al. Interaction at clinical level between erythrocyte acid phosphatase and adenosine deaminase genetic polymorphisms. Hum Genet 82 (1989) 213-215
9. Rudbeck L., Dissing J., Lazaruk K.D., et al. Human 18 kDa phosphotyrosine protein phosphatase (ACP1) polymorphism: studies of rare variants provide evidence that substitutions within or near alternatively spliced exons affect splicing result. Ann Hum Genet 64 (2000) 07-116
10. Bottini N., MacMurray J., Peters W., et al. Association of the acid phosphatase (ACP1) gene with triglyceride levels in obese women. Mol Genet Metab 77 (2002) 226-229
11. Rogers P.A., Fisher R.A., and Putt W. An examination of the age-related patterns of decay of acid phosphatase (ACP1) in human red cells from individuals of different phenotypes. Biochem Genet 16 (1978) 727-738
12. Paggi A., Borgiani P., Gloria-Bottini F., et al. Further studies on acid phosphatase in obese subjects. Dis Markers 9 (1991) 1-7
13. Mohrenweiser H.W., and Novotny J.E. ACP1GUA-1-A low-activity variant of human erythrocyte acid phosphatase: association with increased glutathione reductase activity. Am J Hum Genet 34 (1982) 425-433
14. Spencer N., Hopkinson D.A., and Harris H. Quantitative differences and gene dosage in the human red cell acid phosphatase polymorphism. Nature 201 (1964) 299-300
15. Hopkinson D.A., Spencer N., and Harris H. Red cell acid phosphatase variants: a new human polymorphism. Nature 199 (1963) 969-971
16. Krouf D., Bouchenak M., Mohammedi B., et al. Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects. Med Sci Monit 9 (2003) 109-115
17. Chaves F.J., Mansego M.L., Blesa S., et al. Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens 20 (2007) 62-69
18. Gariballa S., and Ullegaddi R. Riboflavin status in acute ischaemic stroke. Eur J Clin Nutr 61 (2007) 1237-1240
19. Alho I., Bicho M.C., Carvalho R., et al. Low molecular weight protein tyrosine phosphatase genetic polymorphism and susceptibility for cancer development. Cancer Genet Cytogenet 181 (2008) 20-24
20. Marques F., Crespo M.E., Silva Z.I., et al. Insulin and high glucose modulation of phosphates and reductase enzymes in the human erythrocytes: a comparative analysis in normal and diabetic states. Diabetes Res Clin Pract 47 (2000) 191-198
21. Lahiri D.K., and Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
22. Dissing J., Dahl O., and Svensmark O. Phosphonic and arsonic acids as inhibitors of human red cell acid phosphatase and their use in affinity chromatography. Biochim Biophys Acta 569 (1979) 159-176
23. Beutler E. Red cell metabolism. A manual of biochemical methods (1971), Grune & Stratton, New York
24. Bottini E., Lucarini N., Gerlini G., et al. Enzyme polymorphism and clinical variability of diseases: study of acid phosphatase locus 1 (ACP1) in obese subjects. Hum Biol 62 (1990) 403-411
25. Murray R.K., et al. Harper's biochemistry (2000), Appleton & Lange, Stamford (Conn)
26. Luo W., Cao J., Li J., et al. Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress. Exp Gerontol 43 (2008) 154-163
27. Dandona P., Mohanty P., Ghanim H., et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 86 (2001) 355-362
28. Mohanty P., Ghanim H., Hamouda W., et al. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 75 (2002) 767-772
29. Mohanty P., Hamouda W., Garg R., et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85 (2000) 2970-2973
30. ljada A., Mohanty P., Ghanim H., et al. Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 79 (2004) 682-690
31. Merchant A.T., Msamanga G., Villamor E., et al. Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension. J Nutr 135 (2005) 1776-1781
32. Bottini N., Magrini A., Cosmi E., et al. Genetics of signal transduction and the effect of maternal smoking on sex ratio of offspring. Am J Hum Biol 16 (2004) 588-592
33. Bose K.S., and Agrawal B.K. Effect of lycopene from tomatoes (cooked) on plasma antioxidant enzymes, lipid peroxidation rate and lipid profile in grade-I hypertension. Ann Nutr Metab 51 (2007) 477-481
34. Sailaja Y.R., Baskar R., and Saralakumari D. The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics. Free Radic Biol Med 35 (2003) 133-139
35. Colak E., Majkić-Singh N., Stanković S., et al. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med 37 (2005) 613-620
36. Kim S.H., Kim J.S., Shin H.S., et al. Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition 19 (2003) 240-243
37. Barnouin J., Peŕez Cristiá R., Chassagne M., et al. Vitamin and nutritional status in Cuban smokers and nonsmokers in the context of an emerging epidemic neuropathy. Int J Vitam Nutr Res 70 (2000) 126-138
38. Codoñer-Franch P., Bataller A.A., Domingo Camarasa J.V., et al. Influence of dietary lipids on the erythrocyte antioxidant status of hypercholesterolaemic children. Eur J Pediatr (2008) 10.1007/s00431-008-0762-6
39. Serdar Z., Aslan K., Dirican M., et al. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 39 (2006) 794-803
40. Champe P.C., Harvey R.A., Ferrier D.R., et al. Lippincott's illustrated biochemistry reviews: biochemistry (2007), Lippincott's and Williams
41. Yuvaraj S., Premkumar V.G., Vijayasarathy K., et al. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins. Clin Biochem 40 (2007) 623-628
42. Reddi A.S. Riboflavin nutritional status and flavoprotein enzymes in normal and genetically diabetic KK mice. Metabolism 27 (1978) 531-537
43. Reddi A.S. Riboflavin nutritional status and flavoprotein enzymes in streptozotocin-diabetic rats. Biochim Biophys Acta 882 (1986) 71-76
44. McNulty H., Dowey le R.C., Strain J.J., et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation 113 (2006) 74-80
45. Allard M.L., Jeejeebhoy K.N., and Sole M.J. The management of conditioned nutritional requirements in heart failure. Heart Fail Rev 11 (2006) 75-82
46. Witte K.K., Nikitin N.P., Parker A.C., et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 26 (2005) 2238-2244